Geert-Jan Mulder
InvestorCo-founding Managing Partner at Forbion · Board director at Exosome Diagnostics
Naarden, Netherlands
Writes $100K – $5M checks · typically $1.5M
Find your path to Geert-Jan
91 people in our graph share verified history with Geert-Jan — schools, employers, funds. One of them is your warm intro.
About
Geert-Jan Mulder is a co-founding Managing Partner at Forbion who has led investments across Europe and the US and works with portfolio company management teams on clinical development strategy and regulatory matters such as IND/NDA filings and orphan designations. Before Forbion, he was an Investment Director at ABN AMRO Capital Life Sciences from 2001, and earlier held roles in the pharmaceutical industry at Byk Gulden (now Takeda) as Clinical Research Manager and at Searle (now Pfizer) as Medical Adviser. He holds a Medical Degree from the University of Utrecht and completed two years of residency in Obstetrics and Gynaecology at the University Medical Centre of Utrecht.
Invests in
Biotech
Board director at Exosome Diagnostics
Intro paths
In turn, Geert-Jan can intro founders to Exosome Diagnostics's investors below.
Exosome Diagnostics's investors · 2
Co-founders at Exosome Diagnostics
Experience
- Forbion Capital PartnersManaging Partnercurrent2006 — presentNaarden
- Transave Inc.CMO (interim)2006
- ABN AMRO Bank N.V.Director2001 — 2006Amsterdam en omgeving, Nederland
- Byk GuldenClinical Research Manager1999 — 2001
- SearleMedical Adviser1998 — 1999
Skills & more
From Geert-Jan's professional profile.
Deals · 1
Exosome DiagnosticsBoard seat
via Forbion · filed Jul 2015 · $2.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Acordabluebird bioEnterprise TherapeuticsKaNDy TherapeuticsMarianaPanGeneticsPromediorSanifitTransave
Sources: the firm's website · SEC Form D filings.
Colleagues at Forbion
Network5
Investors connected to Geert-Jan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Geert-Jan Mulder?
- Geert-Jan Mulder is a co-founding Managing Partner at Forbion who has led investments across Europe and the US and works with portfolio company management teams on clinical development strategy and regulatory matters such as IND/NDA filings and orphan designations. Before Forbion, he was an Investment Director at ABN AMRO Capital Life Sciences from 2001, and earlier held roles in the pharmaceutical industry at Byk Gulden (now Takeda) as Clinical Research Manager and at Searle (now Pfizer) as Medical Adviser. He holds a Medical Degree from the University of Utrecht and completed two years of residency in Obstetrics and Gynaecology at the University Medical Centre of Utrecht.
- Where does Geert-Jan Mulder work?
- Geert-Jan Mulder is Co-founding Managing Partner at Forbion and Board director at Exosome Diagnostics.
- What does Geert-Jan Mulder invest in?
- Geert-Jan Mulder invests in Biotech.
- What check size does Geert-Jan Mulder write?
- Geert-Jan Mulder typically writes checks of $100K – $5M.
- What boards does Geert-Jan Mulder sit on?
- Geert-Jan Mulder holds tracked board seats at Exosome Diagnostics.
- What companies has Geert-Jan Mulder invested in?
- Investments tracked here include Acorda, bluebird bio, Enterprise Therapeutics, Exosome Diagnostics, KaNDy Therapeutics, Mariana, PanGenetics, Promedior, Sanifit, Transave.
- Where did Geert-Jan Mulder go to school?
- Geert-Jan Mulder studied at Utrecht Medical School - University of Utrecht (Medical Degree (arts)); Conservatory of Utrecht (Flute - jazz and classical music); Registration by Dutch Society of Pharmaceutical Physicians (NVFG) (Pharmaceutical Physician).
- Does Geert-Jan Mulder lead rounds?
- Yes — Geert-Jan Mulder has led 10 tracked investments.
Shared employers
Also worked at ABN AMRO Bank N.V.242
+ 236 more
